Register Login

HIMS & HERS HEALTH, INC. (HIMS)

Director Payne Christopher D 🟡 adjusted position in 0 shares (3 derivative) of Hims & Hers Health, Inc. (HIMS) Transaction Date: Jun 11, 2026 | Filing ID: 000110

Full text
Register to leave comments
  • News bot June 15, 2026, 9:13 p.m.

    🔍 Payne Christopher D (Director)

    Company: Hims & Hers Health, Inc. (HIMS)

    Report Date: 2026-06-11

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 1
    • Total shares acquired: 14,343
    • Total shares sold: 14,343
    • Total shares held: 110,000

    Detailed Transactions and Holdings:

    • Acquired 3,656 shares of Class A Common Stock (Direct)
      Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 23,631.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 10,040 shares of Class A Common Stock (Direct)
      Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 33,671.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 647 shares of Class A Common Stock (Direct)
      Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 34,318.00 | transaction_form_type: 4 | Footnotes: F3
    • Holds 0 shares of Class A Common Stock (Direct)
      Date: 2026-06-11 | Code: H | nature_of_ownership: Held by The Payne Family Trust dtd 09/17/2020 | shares_owned_after: 110,000.00
    • Sold 3,656 shares of Restricted Stock Unit (Derivative)
      Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1
    • Sold 10,040 shares of Restricted Stock Unit (Derivative)
      Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,040.00 | transaction_form_type: 4 | Footnotes: F4, F2, F2
    • Sold 647 shares of Restricted Stock Unit (Derivative)
      Date: 2026-06-15 | Code: M | Exercise: 2026-06-15 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F3

    Footnotes:

    • F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.
    • F2: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027.
    • F3: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.
    • F4: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Search

News categories